SEC Form 4 · accession 0001127602-15-008725
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Feb 25, 2015
Accepted (ET)
Feb 27, 2015 · 9:41 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 25, 2015 | M | 35,538 | $37.03 | A | 360,083 | D | |
| Common Stock | Feb 25, 2015 | S | 200 | $75.53 | D | 359,883 | D | |
| Common Stock | Feb 25, 2015 | S | 500 | $75.72 | D | 359,383 | D | |
| Common Stock | Feb 25, 2015 | S | 200 | $75.78 | D | 359,183 | D | |
| Common Stock | Feb 25, 2015 | S | 500 | $75.85 | D | 358,683 | D | |
| Common Stock | Feb 25, 2015 | S | 100 | $75.86 | D | 358,583 | D | |
| Common Stock | Feb 25, 2015 | S | 300 | $75.88 | D | 358,283 | D | |
| Common Stock | Feb 25, 2015 | S | 200 | $75.90 | D | 358,083 | D | |
| Common Stock | Feb 25, 2015 | S | 100 | $75.9075 | D | 357,983 | D | |
| Common Stock | Feb 25, 2015 | S | 100 | $75.94 | D | 357,883 | D | |
| Common Stock | Feb 25, 2015 | S | 400 | $75.95 | D | 357,483 | D | |
| Common Stock | Feb 25, 2015 | S | 300 | $75.97 | D | 357,183 | D | |
| Common Stock | Feb 25, 2015 | S | 100 | $75.99 | D | 357,083 | D | |
| Common Stock | Feb 25, 2015 | S | 100 | $76.01 | D | 356,983 | D | |
| Common Stock | Feb 25, 2015 | S | 21 | $76.03 | D | 356,962 | D | |
| Common Stock | Feb 25, 2015 | S | 100 | $76.04 | D | 356,862 | D | |
| Common Stock | Feb 25, 2015 | S | 100 | $76.05 | D | 356,762 | D | |
| Common Stock | Feb 25, 2015 | S | 100 | $76.085 | D | 356,662 | D | |
| Common Stock | Feb 25, 2015 | S | 100 | $76.09 | D | 356,562 | D | |
| Common Stock | Feb 25, 2015 | S | 200 | $76.17 | D | 356,362 | D | |
| Common Stock | Feb 25, 2015 | S | 100 | $76.205 | D | 356,262 | D | |
| Common Stock | Feb 25, 2015 | S | 300 | $76.22 | D | 355,962 | D | |
| Common Stock | Feb 25, 2015 | S | 100 | $76.265 | D | 355,862 | D | |
| Common Stock | Feb 25, 2015 | S | 100 | $76.2975 | D | 355,762 | D | |
| Common Stock | Feb 25, 2015 | S | 200 | $76.32 | D | 355,562 | D | |
| Common Stock | Feb 25, 2015 | S | 100 | $76.3275 | D | 355,462 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $37.03 | Feb 25, 2015 | M | 35,538 | D | Feb 25, 2012 | Feb 25, 2018 | Common Stock | 35,538 | 0 | D |
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.